Table 1 Baseline characteristics and predictor analysis of mortality
Variables | Findings | Odds Ratio (95%CI) | p-value |
|---|---|---|---|
Age | 30 (18–61) | 1.04 (0.96–1.13) | 0.263 |
Sex | M: F = 38:8 | 0.42 (0.02–8.41) | 0.569 |
OR first | 25 (54.3%) | 11.5 (0.60–222.1) | 0.105 |
Preoperative Imaging | 26/46 (56.5%) | 0.22 (0.031–1.51) | 0.123 |
Organ Injury | |||
Liver | 27 (52.2%) | 1.0 (0.18–5.67) | 1.00 |
Spleen | 6 (13.0%) | 2.21 (0.28–17.25) | 0.449 |
Kidney | 7 (15.2%) | 0.418 (0.02–8.41) | 0.569 |
Hollow Organs | 18 (39.1%) | 23.22 (1.20–451.11) | 0.038 |
Pancreas | 2 (4.3%) | 9.0 (0.77–105.75) | 0.08 |
Adrenal Glands | 2 (4.3%) | 1.44 (0.061–34.01) | 0.823 |
Lung/Thorax | 27 (58.7%) | 1.95 (0.0281.37) | 0.101 |
Spine | 6 (13.0%) | 0.496 (0.024–10.11) | 0.649 |
Shoulder/Buttock | 8 (17.4%) | 0.358 (0.018–7.13) | 0.501 |
Extremities | 22 (47.8%) | 15.4 (0.80–297.00) | 0.070 |
Pelvis | 11 (23.9%) | 2.44 (0.41–14.44) | 0.324 |
Contrast Extravasation | 35 (76.1%) | 1.0 (0.14–7.21) | 1.01 |
Treatment Material | |||
Coil | 34 (73.9%) | 4.66 (0.24–90.82) | 0.310 |
Gel foam | 22 (47.8%) | 3.81 (0.54–26.67) | 0.178 |
Stent graft | 3 (6.5%) | 1.00 (0.045–22.09) | 1.00 |
Empiric Embolization | 6 (13.0%) | 4.74 (0.74–30.27) | 0.10 |
Laboratory Value | |||
Hemoglobin | 12.1 (7.0–19.0) | 0.896 (0.63–1.27) | 0.534 |
Platelet | 184.5 (48–408) | 1.00 (0.99–1.01) | 0.772 |
INR | 1.2 (0.9–9.3) | 1.13 (0.75–1.70) | 0.570 |
ISS | 44.2 (2.4) | 1.05 (0.99–1.11) | 0.125 |
RTS | 7.7 (0.5) | 1.18 (1.00–1.39) | 0.056 |
TRISS | 12.4 (9.5) | 0.97 (0.95–1.00) | 0.066 |
APACHE II | 7.4 (0.8) | 1.16 (1.00–1.35) | 0.053 |